Sanofi company, Genzyme has received approval of a product label expansion from the European Commission for the use of Thyrogen (thyrotropin alfa) with a broad irradiation dose range for postoperative thyroid remnant ablation. The ...
Tags: label, postoperative thyroid remnant ablation, revised labeling
The European Commission has cleared the expanded use of Genzyme's Thyrogen(thyrotropin alfa)cancer therapy for patients with postoperative thyroid remnant ablation. The new approval allows administration of a reduced dose of radioiodine ...
Tags: European Commission, Genzyme, Thyrogen, cancer therapy